0001209191-16-136329.txt : 20160810
0001209191-16-136329.hdr.sgml : 20160810
20160810164343
ACCESSION NUMBER: 0001209191-16-136329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160809
FILED AS OF DATE: 20160810
DATE AS OF CHANGE: 20160810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Epizyme, Inc.
CENTRAL INDEX KEY: 0001571498
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261349956
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-229-5872
MAIL ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Singer Andrew E.
CENTRAL INDEX KEY: 0001632720
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35945
FILM NUMBER: 161821982
MAIL ADDRESS:
STREET 1: C/O EPIZYME, INC.
STREET 2: 400 TECHNOLOGY SQUARE, 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-09
0
0001571498
Epizyme, Inc.
EPZM
0001632720
Singer Andrew E.
C/O EPIZYME, INC.
400 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
0
1
0
0
EVP & CFO
Common Stock, par value $0.0001
2016-08-09
4
M
0
1682
A
26274
D
Common Stock, par value $0.0001
2016-08-09
4
M
0
778
A
27052
D
Common Stock, par value $0.0001
2016-08-09
4
S
0
1013
9.0479
D
26039
D
Restricted Stock Units
2016-08-09
4
M
0
1682
0.00
D
Common Stock
1682
50457
D
Restricted Stock Units
2016-08-09
4
M
0
778
0.00
D
Common Stock
778
23320
D
Each restricted stock unit represents the contingent right to receive one share of Epizyme, Inc. common stock upon vesting.
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person to cover taxes associated with the vesting of his restricted stock.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.01 per share to $9.29 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This award, granted on February 9, 2016, pursuant to the reporting person's employment agreement, dated January 23,2015, vests as to 25% of the total award on February 9, 2016, a year from the commencement of employment, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.
This award, granted on February 9, 2015, pursuant to the Company's 2013 Stock Inventive Plan, vests as to 25% of the total award on February 9, 2016, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.
/s/ Adriana Sullivan, attorney-in-fact
2016-08-10